Article

Barriers to the use of herpes zoster vaccine.

The Children's Hospital of Denver, University of Colorado Denver, USA.
Annals of internal medicine (Impact Factor: 16.1). 05/2010; 152(9):555-60. DOI: 10.1059/0003-4819-152-9-201005040-00005
Source: PubMed

ABSTRACT The herpes zoster vaccine is the most expensive vaccine recommended for older adults and the first vaccine to be reimbursed through Medicare Part D. Early uptake has been 2% to 7% nationally.
To assess current vaccination practices, knowledge and practice regarding reimbursement, and barriers to vaccination among general internists and family medicine physicians.
Mail and Internet-based survey, designed through an iterative process and conceptually based on the Health Belief Model.
National survey conducted from July to September 2008.
General internists and family medicine physicians.
Survey responses on current vaccination practices, knowledge and practice regarding reimbursement, and barriers to vaccination.
Response rates were 72% in both specialties (301 general internists and 297 family medicine physicians). Physicians in both specialties reported similar methods for delivering vaccine, which included stocking and administering the vaccine in their offices (49%), referring patients to a pharmacy to purchase the vaccine and bring it back to the office for administration (36%), and referring patients to a pharmacy for vaccine administration (33%). Eighty-eight percent of providers recommend herpes zoster vaccine and 41% strongly recommend it, compared with more than 90% who strongly recommend influenza and pneumococcal vaccines. For physicians in both specialties, the most frequently reported barriers to vaccination were financial. Only 45% of respondents knew that herpes zoster vaccine is reimbursed through Medicare Part D. Of respondents who began administering herpes zoster vaccine in their office, 12% stopped because of cost and reimbursement issues.
Survey results represent reported but not observed practice. Surveyed providers may not be representative of all providers.
Physicians are making efforts to provide herpes zoster vaccine but are hampered by barriers, particularly financial ones. Efforts to facilitate the financing of herpes zoster vaccine could help increase its use.
Centers for Disease Control and Prevention.

0 Followers
 · 
118 Views
  • 09/2012; 22(4):20-25. DOI:10.1093/ppar/22.4.20
  • [Show abstract] [Hide abstract]
    ABSTRACT: Preventative health services, including herpes zoster vaccination rates, remain low despite known benefits. A new care model to improve preventative health services is warranted. The objective of this study is to investigate whether the functions of an electronic medical record, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate. This study was a 6-month, randomized controlled trial at a General Internal Medicine clinic at The Ohio State University. The 2589 patients aged 60 years and older without documented herpes zoster vaccination in the electronic medical record were stratified on the basis of activated personal health record status, an online tool used to share health information between patient and provider. Of the 674 personal health record users, 250 were randomized to receive information regarding the herpes zoster vaccination via an electronic message and 424 were randomized to standard of care. Likewise, of the 1915 nonpersonal health record users, 250 were randomized to receive the same information via the US Postal Service and 1665 were randomized to standard of care. After pharmacist chart review, eligible patients were mailed a herpes zoster vaccine prescription. Herpes zoster vaccination rates were compared by chi-square tests. Intervention recipients had significantly higher vaccination rates than controls in both personal health record (relative risk, 2.7; P = .0007) and nonpersonal health record (relative risk, 2.9; P = .0001) patient populations. Communication outside of face-to-face office visits, by both personal health record electronic message and information by mail, can improve preventative health intervention rates compared with standard care.
    The American journal of medicine 07/2013; 126(9). DOI:10.1016/j.amjmed.2013.02.018 · 5.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: 1. Identify patient characteristics, awareness and knowledge associated with herpes zoster (HZ) vaccination status. 2. Identify self-reported reasons for not receiving Zostavax(®). 3. Assess the impact of a patient education program by measuring post-intervention interest in obtaining the Zostavax(®) vaccine across reasons for being unvaccinated.
    Vaccine 08/2014; 32(43). DOI:10.1016/j.vaccine.2014.08.040 · 3.49 Impact Factor